Document ID: chunk:federal_register_of_legislation:F2021L01162:reg:9:p5
Version: federal_register_of_legislation:F2021L01162
Segment Type: reg
Provision Reference: reg 9 (pt 5/6)
Character Range: 14928–18049

disease;
Note: hard metal is defined in the Schedule 1 - Dictionary.
(34)      inhaling a toxic gas or fumes resulting in:
(a)          signs and symptoms of severe acute lower respiratory damage requiring medical attention within 48 hours after exposure; and
(b)          the persistence of respiratory signs and symptoms for at least 1 week after exposure, within the 1 year before the clinical worsening of fibrosing interstitial lung disease;
            Note: Types of toxic gases or fumes include anhydrous ammonia fumes, smoke, oxides of sulphur, oxides of nitrogen, chlorine, phosgene, humidifier detergents, perfluoroisobutylene (may be released in fires of military vehicles containing Teflon) and zinc chloride smoke from smoke bombs.
(35)      having paraquat poisoning within the 6 months before the clinical worsening of fibrosing interstitial lung disease;
Note: paraquat is defined in the Schedule 1 - Dictionary.
(36)      inhaling mustard gas within the 20 years before the clinical worsening of fibrosing interstitial lung disease;
(37)      having received a cumulative equivalent dose of at least 0.2 sievert of ionising radiation to the lung at least 6 months before the clinical worsening of fibrosing interstitial lung disease;
Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.
(38)      undergoing a course of therapeutic radiation for cancer, where the affected lung was in the field of radiation, at least 6 months before the clinical worsening of fibrosing interstitial lung disease;
(39)      having received iodine-131 (radioactive iodine) as therapy for widespread pulmonary metastases from a malignant neoplasm of the thyroid, at least 6 months before the clinical worsening of fibrosing interstitial lung disease;
(40)      having received yttrium-90 microspheres as therapy for primary or metastatic liver tumours, at least 3 months before the clinical worsening of fibrosing interstitial lung disease;
(41)      having acute respiratory distress syndrome within the 6 months before the clinical worsening of fibrosing interstitial lung disease;
Note: acute respiratory distress syndrome is defined in the Schedule 1 - Dictionary.
(42)      being treated with a cytotoxic agent for a malignant neoplasm or in association with haematopoietic stem cell transplantation, before the clinical worsening of fibrosing interstitial lung disease;
(43)      taking a drug from the specified list of drugs within the 6 months before the clinical worsening of fibrosing interstitial lung disease;
Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(44)      having chronic or recurrent diffuse alveolar haemorrhage before the clinical worsening of fibrosing interstitial lung disease;
            Note: diffuse alveolar haemorrhage is defined in the Schedule 1 - Dictionary.
(45)      having exogenous lipoid pneumonitis at the time of the clinical worsening of fibrosing interstitial lung disease;
Note: exogenous lipoid pneumonitis is defined in the Schedule 1 - Dictionary.
(46)      having tropical pulmonary eosinophilia for at least the 6 months